Corporate News
Coloplast (COLO‑B.CO) traded down by 1.12 % during a 24‑hour period ending at 09:18 AM Central Europe on Wednesday, 21 April. A single share can be purchased for approximately DKK 470.6 on the most liquid exchanges. The company’s current supply stands at 225.2 million shares, giving it a market capitalization of DKK 105.4 billion. In the last 24 hours, roughly DKK 99 million of Coloplast shares were exchanged.
Since the end of last month, Coloplast’s shares have risen 11.03 %. The 200‑day simple moving average sits at DKK 442.58, while the 52‑week high—recorded on 11 May 2025—reached DKK 631.4. The 52‑week low, set on 18 June 2026, stands at DKK 369.7.
Market Context
Coloplast’s modest price movement on Tuesday reflected a broader lift among Danish healthcare names. The stock advanced by roughly two percent, matching the performance of several other medicine‑sector companies that outperformed the market that day. Analysts noted that the sector benefited from a rotation away from more volatile AI‑related stocks. Although the lift was moderate, it aligned with the overall trend of defensive, health‑related shares gaining traction. The day’s calm trading session saw the C25 index finish marginally higher, further supporting the health‑sector momentum.
Performance of Peer Stocks
| Stock | Recent Change | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| Alk‑abello A/ (ALK‑B.CO) | +4.22 % | DKK 240.6 | DKK 52.6 bn | 38.24 |
| Tryg A/ (TRYG.CO) | +0.39 % | DKK 154.8 | DKK 91.4 bn | 19.75 |
| Ascendis Pharma A/ (A710.F) | 0 % | EUR 208 | EUR 13.3 bn | 18.12 |
| Pandora A/ (PNDORA.CO) | –0.12 % | DKK 837.2 | DKK 60 bn | 12.44 |
| Demant A/ (DEMANT.CO) | +0.28 % | DKK 361.6 | DKK 75.6 bn | 31.05 |
Alk‑abello’s notable gain was highlighted in a retail‑focused investment story that featured a young participant who added shares of the company to a portfolio concentrated on domestic firms. A separate regulatory short‑position report indicated only a modest short‑interest level for Alk‑abello, suggesting limited bearish coverage in the current market environment.
Company Overview
Coloplast A/S is a global healthcare equipment and supply company headquartered in Humlebaek, Denmark. The firm specializes in the development and marketing of intimate healthcare products and services across three core segments:
- Chronic Care – products for long‑term conditions such as incontinence and ostomy care.
- Interventional Urology – devices and solutions for urological procedures.
- Wound & Skin Care – advanced dressings and therapies for wound management.
For more detailed information on Coloplast’s offerings and operations, visit its website at www.coloplast.com . The company is listed on the OMX Nordic Exchange Copenhagen AS.
This article provides an overview of Coloplast’s recent trading performance, contextual market movements, and a snapshot of related peer stocks, all aimed at delivering clear, accessible insights into current corporate dynamics.
